298 related articles for article (PubMed ID: 22972494)
21. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.
Becker C; Fantini MC; Schramm C; Lehr HA; Wirtz S; Nikolaev A; Burg J; Strand S; Kiesslich R; Huber S; Ito H; Nishimoto N; Yoshizaki K; Kishimoto T; Galle PR; Blessing M; Rose-John S; Neurath MF
Immunity; 2004 Oct; 21(4):491-501. PubMed ID: 15485627
[TBL] [Abstract][Full Text] [Related]
22. Overcoming the hurdles in using mouse genetic models that block TGF-beta signaling.
Sanjabi S; Flavell RA
J Immunol Methods; 2010 Feb; 353(1-2):111-4. PubMed ID: 20060833
[TBL] [Abstract][Full Text] [Related]
23. Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy.
Llopiz D; Dotor J; Casares N; Bezunartea J; Díaz-Valdés N; Ruiz M; Aranda F; Berraondo P; Prieto J; Lasarte JJ; Borrás-Cuesta F; Sarobe P
Int J Cancer; 2009 Dec; 125(11):2614-23. PubMed ID: 19530254
[TBL] [Abstract][Full Text] [Related]
24. T-cell receptor gene therapy of established tumors in a murine melanoma model.
Abad JD; Wrzensinski C; Overwijk W; De Witte MA; Jorritsma A; Hsu C; Gattinoni L; Cohen CJ; Paulos CM; Palmer DC; Haanen JB; Schumacher TN; Rosenberg SA; Restifo NP; Morgan RA
J Immunother; 2008 Jan; 31(1):1-6. PubMed ID: 18157006
[TBL] [Abstract][Full Text] [Related]
25. A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension.
Yung LM; Nikolic I; Paskin-Flerlage SD; Pearsall RS; Kumar R; Yu PB
Am J Respir Crit Care Med; 2016 Nov; 194(9):1140-1151. PubMed ID: 27115515
[TBL] [Abstract][Full Text] [Related]
26. Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.
Novitskiy SV; Pickup MW; Chytil A; Polosukhina D; Owens P; Moses HL
J Leukoc Biol; 2012 Sep; 92(3):641-51. PubMed ID: 22685318
[TBL] [Abstract][Full Text] [Related]
27.
Stüber T; Monjezi R; Wallstabe L; Kühnemundt J; Nietzer SL; Dandekar G; Wöckel A; Einsele H; Wischhusen J; Hudecek M
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303620
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.
Ando Y; Yang GX; Kenny TP; Kawata K; Zhang W; Huang W; Leung PS; Lian ZX; Okazaki K; Ansari AA; He XS; Invernizzi P; Ridgway WM; Lu Q; Gershwin ME
J Autoimmun; 2013 Mar; 41():111-9. PubMed ID: 23395552
[TBL] [Abstract][Full Text] [Related]
29. TGF-beta insensitive dendritic cells: an efficient vaccine for murine prostate cancer.
Wang FL; Qin WJ; Wen WH; Tian F; Song B; Zhang Q; Lee C; Zhong WD; Guo YL; Wang H
Cancer Immunol Immunother; 2007 Nov; 56(11):1785-93. PubMed ID: 17473921
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development.
Ouyang W; Beckett O; Ma Q; Li MO
Immunity; 2010 May; 32(5):642-53. PubMed ID: 20471291
[TBL] [Abstract][Full Text] [Related]
31. Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma.
Yvon ES; Burga R; Powell A; Cruz CR; Fernandes R; Barese C; Nguyen T; Abdel-Baki MS; Bollard CM
Cytotherapy; 2017 Mar; 19(3):408-418. PubMed ID: 28109751
[TBL] [Abstract][Full Text] [Related]
32. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
Zhang Q; Jang TL; Yang X; Park I; Meyer RE; Kundu S; Pins M; Javonovic B; Kuzel T; Kim SJ; Van Parijs L; Smith N; Wong L; Greenberg NM; Guo Y; Lee C
Prostate; 2006 Feb; 66(3):235-47. PubMed ID: 16173028
[TBL] [Abstract][Full Text] [Related]
33. IL7-Fc Enhances the Efficacy of Adoptive T Cell Therapy under Lymphopenic Conditions in a Murine Melanoma Model.
Yu EM; Cho E; Singh R; Kim SH; Han C; Han S; Lee DG; Kim YH; Kwon BS; Choi BK
Cells; 2021 Aug; 10(8):. PubMed ID: 34440787
[TBL] [Abstract][Full Text] [Related]
34. Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.
Kosaka A; Ohkuri T; Ikeura M; Kohanbash G; Okada H
Biochem Biophys Res Commun; 2015 Mar; 458(3):549-554. PubMed ID: 25677619
[TBL] [Abstract][Full Text] [Related]
35. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
Suzuki E; Kapoor V; Cheung HK; Ling LE; DeLong PA; Kaiser LR; Albelda SM
Clin Cancer Res; 2004 Sep; 10(17):5907-18. PubMed ID: 15355924
[TBL] [Abstract][Full Text] [Related]
36. Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation.
Ince MN; Elliott DE; Setiawan T; Metwali A; Blum A; Chen HL; Urban JF; Flavell RA; Weinstock JV
Eur J Immunol; 2009 Jul; 39(7):1870-8. PubMed ID: 19544487
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
38. TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma.
Liu J; Liao S; Diop-Frimpong B; Chen W; Goel S; Naxerova K; Ancukiewicz M; Boucher Y; Jain RK; Xu L
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16618-23. PubMed ID: 22996328
[TBL] [Abstract][Full Text] [Related]
39. Chimeric extracellular domain type II transforming growth factor (TGF)-beta receptor fused to the Fc region of human immunoglobulin as a TGF-beta antagonist.
Komesli S; Vivien D; Dutartre P
Eur J Biochem; 1998 Jun; 254(3):505-13. PubMed ID: 9688260
[TBL] [Abstract][Full Text] [Related]
40. TGF-β cytokine signaling promotes CD8+ T cell development and low-affinity CD4+ T cell homeostasis by regulation of interleukin-7 receptor α expression.
Ouyang W; Oh SA; Ma Q; Bivona MR; Zhu J; Li MO
Immunity; 2013 Aug; 39(2):335-46. PubMed ID: 23932572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
